Tom C. Karagiannis
Orcid: 0000-0002-9967-1546
According to our database1,
Tom C. Karagiannis
authored at least 9 papers
between 2018 and 2024.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2024
Investigation of RNA-binding protein NOVA1 in silico: Comparison of the modern human V197 with the archaic I197 variant present in Neanderthals.
Comput. Biol. Medicine, 2024
2022
Identification of novel bioactive compounds from <i>Olea europaea</i> by evaluation of chemical compounds in the OliveNet™ library: <i>in silico</i> bioactivity and molecular modelling, and <i>in vitro</i> validation of hERG activity.
Comput. Biol. Medicine, 2022
Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
Comput. Biol. Medicine, 2022
2020
Interaction of small molecules with the SARS-CoV-2 main protease <i>in silico</i> and <i>in vitro</i> validation of potential lead compounds using an enzyme-linked immunosorbent assay.
Comput. Biol. Chem., 2020
Molecular docking utilising the OliveNet™ library reveals novel phenolic compounds which may potentially target key proteins associated with major depressive disorder.
Comput. Biol. Chem., 2020
Utilisation of the OliveNet™ Library to investigate phenolic compounds using molecular modelling studies in the context of Alzheimer's disease.
Comput. Biol. Chem., 2020
Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex.
Comput. Biol. Chem., 2020
Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.
Comput. Biol. Chem., 2020
2018
Database J. Biol. Databases Curation, 2018